Search

Author/Creator Angevin, E.

1. 505 Clinical evidence of intra-tumoral immune activation and tumor targeting with RG, a CEA-targeted engineered IL-2 immunocytokine. (September 2015)

Authors:
Tabernero, J.; Homicsko, K.; Schellens, J.H.; Hoekstra, O.; Van der Veen, L.; Melero, I.; és, G. Argil; Mau-Sorensen, M.; Angevin, E.; Joensuu, H.; Van Brummelen, E.; van Oordt, C.W. Menke-van der Houven; Nayak, T.; Romagnoli, S.; Reis, B.; Brossard, S. Soehrman; Evers, S.; Saro, J.; Verheul, H.;...
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy. Issue 3 (September 2015)

Authors:
Kossai, M.; Duchemann, B.; Boutros, C.; Caramella, C.; Hollebecque, A.; Angevin, E.; Gazzah, A.; Bahleda, R.; Ileana, E.; Massard, C.; Vielh, P.; Soria, J.C.; Besse, B.
Journal:
Lung cancer
Issue:
Volume 89:Issue 3(2015:Sep.)
Page Start:
306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. (February 2016)

Authors:
Michot, J.M.; Bigenwald, C.; Champiat, S.; Collins, M.; Carbonnel, F.; Postel-Vinay, S.; Berdelou, A.; Varga, A.; Bahleda, R.; Hollebecque, A.; Massard, C.; Fuerea, A.; Ribrag, V.; Gazzah, A.; Armand, J.P.; Amellal, N.; Angevin, E.; Noel, N.; Boutros, C.; Mateus, C.
Journal:
European journal of cancer
Issue:
Volume 54(2016)
Page Start:
139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. (February 2016)

Authors:
Michot, J.M.; Bigenwald, C.; Champiat, S.; Collins, M.; Carbonnel, F.; Postel-Vinay, S.; Berdelou, A.; Varga, A.; Bahleda, R.; Hollebecque, A.; Massard, C.; Fuerea, A.; Ribrag, V.; Gazzah, A.; Armand, J.P.; Amellal, N.; Angevin, E.; Noel, N.; Boutros, C.; Mateus, C.
Journal:
European journal of cancer
Issue:
Volume 54(2016)
Page Start:
139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours. (August 2017)

Authors:
Hollebecque, A.; Bahleda, R.; Faivre, L.; Adam, J.; Poinsignon, V.; Paci, A.; Gomez-Roca, C.; Thery, J.C.; Le Deley, M.C.; Varga, A.; Gazzah, A.; Ileana, E.; Gharib, M.; Angevin, E.; Malekzadeh, K.; Massard, C.; Soria, J.C.; Spano, J.P.
Journal:
European journal of cancer
Issue:
Volume 81(2017)
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. SAFETY PROFILE OF COMBINATION THERAPY WITH IMMUNE CHECKPOINT BLOCKERS AND VEGF INHIBITORS IN OLDER PATIENTS TREATED IN EARLY PHASE CLINICAL TRIALS. (November 2019)

Authors:
Baldini, C.; Romano, P.Martin; Vincent, H.; Vuagnat, P.; Champiat, S.; Michot, J.; Bahleda, R.; Gazzah, A.; Vinay, S.Postel; Hollebecque, A.; Angevin, E.; Ribrag, V.; Loriot, Y.; Marabelle, A.; Massard, C.; Varga, A.
Journal:
Journal of geriatric oncology
Issue:
Volume 10(2019)Supplement 1
Page Start:
S108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗